Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2023-07-06 00:00:00 ET · period of report 2023-07-03 · accession 0001968202-23-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-06 | 2023-07-03 | REGN | McCourt Marion | EVP Commercial | S - Sale | $710.09 | -250 | 20.3K | -1% | -$177.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-03 | S | D | 250 | $710.09 | 20,303 | D | — | — |